[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

Chondrosarcoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Chondrosarcoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Chondrosarcoma pipeline...

February 2023 190 pages

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023...

February 2023 60 pages

Chronic Urticaria or Hives Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Chronic Urticaria or Hives Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Chronic Urti...

February 2023 190 pages

Cluster Headache Syndrome (Cluster Headache) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Cluster Headache Syndrome (Cluster Headache) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each o...

February 2023 90 pages

Coccidioidomycosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Coccidioidomycosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Coccidioidomycosis p...

February 2023 40 pages

Cognitive Impairment Associated With Schizophrenia (CIAS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Cognitive Impairment Associated With Schizophrenia (CIAS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  202...

February 2023 100 pages

Colitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Colitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Colitis pipeline candidate, det...

February 2023 150 pages

Community Acquired Pneumonia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Community Acquired Pneumonia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Community...

February 2023 90 pages

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under de...

February 2023 50 pages

Contact Dermatitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Contact Dermatitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Contact Dermatitis p...

February 2023 40 pages

Contrast Induced Nephropathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Contrast Induced Nephropathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Contrast I...

February 2023 40 pages

Corneal Neovascularization Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Corneal Neovascularization Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Corneal Neov...

February 2023 40 pages

Cough Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Cough Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Cough pipeline candidate, details...

February 2023 150 pages

Crigler-Najjar Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Crigler-Najjar Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Crigler-Najjar...

February 2023 40 pages

Critical Limb Ischemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Critical Limb Ischemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Critical Limb Is...

February 2023 120 pages

Cryptococcosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Cryptococcosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Cryptococcosis pipeline...

February 2023 50 pages

Cryptosporidiosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Cryptosporidiosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Cryptosporidiosis pip...

February 2023 40 pages

Cytomegalovirus (HHV-5) Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Cytomegalovirus (HHV-5) Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Cyto...

February 2023 190 pages

Deep Vein Thrombosis (DVT) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Deep Vein Thrombosis (DVT) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Deep Vein Th...

February 2023 60 pages

Degenerative Disc Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Degenerative Disc Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Degenerative...

February 2023 90 pages

Dermatomyositis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Dermatomyositis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Dermatomyositis pipelin...

February 2023 90 pages

Diabetic Gastroparesis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Diabetic Gastroparesis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Diabetic Gastrop...

February 2023 40 pages

Diabetic Neuropathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Diabetic Neuropathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Diabetic Neuropathy...

February 2023 150 pages

Diabetic Peripheral Neuropathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Diabetic Peripheral Neuropathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Diabetic...

February 2023 110 pages

Diarrhea Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Diarrhea Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Diarrhea pipeline candidate, d...

February 2023 160 pages

Dilated Cardiomyopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Dilated Cardiomyopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Dilated Cardiomy...

February 2023 50 pages

Diphtheria Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Diphtheria Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Diphtheria pipeline candidat...

February 2023 130 pages

Down Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Down Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Down Syndrome pipeline ca...

February 2023 70 pages

Drug Overdose Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Drug Overdose Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Drug Overdose pipeline ca...

February 2023 100 pages

Eastern Equine Encephalitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Eastern Equine Encephalitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Eastern Equ...

February 2023 40 pages

Elephantiasis (Lymphatic Filariasis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Elephantiasis (Lymphatic Filariasis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the El...

February 2023 40 pages

Encephalomyelitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Encephalomyelitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Encephalomyelitis pip...

February 2023 50 pages

Encephalopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Encephalopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Encephalopathy pipeline...

February 2023 90 pages

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  20...

February 2023 40 pages

Endometriosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Endometriosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Endometriosis pipeline ca...

February 2023 200 pages

Eosinophilic Esophagitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Eosinophilic Esophagitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Eosinophilic E...

February 2023 120 pages

Epidermolysis Bullosa Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Epidermolysis Bullosa Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Epidermolysis Bul...

February 2023 190 pages

Epstein-Barr Virus (HHV-4) Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Epstein-Barr Virus (HHV-4) Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the E...

February 2023 150 pages

Erectile Dysfunction Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Erectile Dysfunction Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Erectile Dysfuncti...

February 2023 200 pages

Escherichia Coli Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Escherichia Coli Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Escherichia...

February 2023 190 pages

Essential Thrombocythemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Essential Thrombocythemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Essential Thr...

February 2023 60 pages

Fabry Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fabry Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Fabry Disease pipeline ca...

February 2023 100 pages

Familial Adenomatous Polyposis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Familial Adenomatous Polyposis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Familial...

February 2023 80 pages

Familial Amyloid Neuropathies Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Familial Amyloid Neuropathies Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Familial...

February 2023 40 pages

Fanconi Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fanconi Anemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Fanconi Anemia pipeline...

February 2023 40 pages

Fatigue Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fatigue Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Fatigue pipeline candidate, det...

February 2023 50 pages

Female Contraception Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Female Contraception Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Female Contracepti...

February 2023 130 pages

Female Hypoactive Sexual Desire Disorder Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Female Hypoactive Sexual Desire Disorder Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of th...

February 2023 40 pages

Female Sexual Dysfunction Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Female Sexual Dysfunction Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Female Sexual...

February 2023 70 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1&...

February 2023 40 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers